Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials.

J Infect Dis · 2022 · PMC9470102 · PMID 34610135

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

In all 5 groups some infants were still shedding at day 56, 28 days after their second vaccination, the highest proportion being after a second mOPV2 dose (39.3%), with a nonsignificant trend for lower proportions after second low or high doses of nOPV2-c1 (17.4% and 33.3%) or nOPV2-c2 (27.8% and 20.0%).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.